Skip Navigation


Mutagenesis Advance Access originally published online on December 8, 2006
Mutagenesis 2007 22(1):83-88; doi:10.1093/mutage/gel063
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/1/83    most recent
gel063v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Arlt, V. M.
Right arrow Articles by Schmeiser, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arlt, V. M.
Right arrow Articles by Schmeiser, H. H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Author 2006. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society. All rights reserved. For permissions, please email: journals.permissions@oxfordjournals.org

ECNIS-sponsored workshop on biomarkers of exposure and cancer risk: DNA damage and DNA adduct detection and 6th GUM-32P-postlabelling workshop, German Cancer Research Center, Heidelberg, Germany, 29–30 September 2006{dagger}

Volker M. Arlt1,*, Eva Frei2 and Heinz H. Schmeiser2

1 Institute of Cancer Research, Section of Molecular Carcinogenesis Brookes Lawley Building, Sutton, Surrey SM2 5NG, UK 2 German Cancer Research Center, Division of Molecular Toxicology INF 280, 69120 Heidelberg, Germany

Speakers: Volker M.Arlt (Institute of Cancer Research, UK), Frederick A.Beland (National Center for Toxicological Research; USA), Karen Brown (University of Leicester, UK), Erwin Eder (University of Würzburg, Germany), Gerhard Eisenbrand (University of Kaiserslautern, Germany), Peter B.Farmer (Biocentre Leicester, UK), Panagiotis Georgiadis (National Hellenic Research Foundation, Greece), Hansruedi Glatt (German Institute of Human Nutrition, Germany), Roger W.Godschalk (University of Maastricht, The Netherlands), Arthur P.Grollman (State University of New York at Stony Brook, USA), Monica Hollstein (German Cancer Research Center, Germany), Werner Lutz (University of Würzburg, Germany), Matilde M.Marques (Technical University of Lisbon, Portugal), Lennart Möller (Karolinska Institute, Sweden), Christopher J.Michejda (National Cancer Institute Frederick, USA), Jagadeesan Nair (German Cancer Research Center, Germany), Marco Peluso (Tuscany Cancer Institute, Italy), Wolfgang Pfau (GAB-Consulting; Germany), David H.Phillips (Institute of Cancer Research, UK), Elmar Richter (University of Munich, Germany), Heinz H.Schmeiser (German Cancer Research Center, Germany), Oliver J.Schmitz (University of Wuppertal, Germany), Bernadette Schoket (National Institute of Environmental Health, Hungary), Dan Segerbäck (Karolinska Institute, Sweden), Albrecht Seidel (Biochemical Institute for Environmental Carcinogens, Germany), Marie Stiborova (Charles University Prague, Czech Republic), Jan Topinka (Institute of Experimental Medicine AS, Czech Republic).

Of all the chemicals classified as carcinogenic to humans by the International Agency for Research on Cancer (IARC), 90% exert their biological effects through binding of their metabolically activated intermediates to DNA forming covalent DNA adducts. As a consequence DNA adducts are generally considered to be causative and directly related to tumour formation. DNA adduct analyses reflect tissue-specific rates of adduct formation and removal, which depend on carcinogen uptake, metabolic activation, DNA repair, adduct instability and tissue turnover and are thus useful markers of carcinogen exposure. The measurement of carcinogen–DNA adduct levels is central to the understanding of chemical carcinogenesis both in animals and humans to determine molecular mechanisms and exposure. Sensitive methods for DNA adduct analysis used to date are based on 32P-postlabelling, immunoassay, mass spectrometry and laser-induced fluorescence. The aim of this workshop held over 2 days (29–30 September 2006) at the German Cancer Research Center (DKFZ) in Heidelberg, Germany, was to discuss methodological improvements of DNA adduct detection with emphasis on the 32P-postlabelling procedure as well as new findings achieved by applying the methods to studies on understanding human cancer mechanisms and to elucidate the relationship between adduct formation and human cancer risk.

{dagger}This workshop was dedicated to Prof. Manfred Wiessler, head of the Division of Molecular Toxicology at the German Cancer Research Center, Heidelberg, Germany, on the occasion of his 65th birthday.

*To whom correspondence should be addressed. Tel: +44 20 8722 4405; Fax: +44 20 8722 4052; Email: volker.arlt{at}icr.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.